Skip to main content
Erschienen in: Endocrine 3/2021

Open Access 20.07.2021 | Letter to the Editor

Letter to “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment”

verfasst von: Sadettin Öztürk, Ersin Akarsu

Erschienen in: Endocrine | Ausgabe 3/2021

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
We read the manuscript entitled “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment” with great interest and pleasure [1]. We thought some points should be clarified so we decided to explain the test result discrepancies. İn the article to determine the absorbtion rate in patients with high levels of thyroid-stimulating hormone (TSH) despite receiving adequate doses of levothyroxine;
% L4 absorbtion: [(peak ΔT4 × volume distribution) ÷ administered dose of LT(μg)] × 100
Volume distribution(dL): 4.42 × body mass index
formula is used and according to the formula, those with an absorbtion result of more than 60–80% are considered normal. Considering the five patients evaluated in the study;
Absorption rates were not consistent with the data in the study Table 1. In addition, very high peakT4 values are required for the 60–80% absorption rate required for the test to be normal. In the study named “The clinical utility of free thyroxine in oral levothyroxine absorption testing”, in which the formula is taken as reference, calculations were made with total T4 and free T4 values and it was observed that similar incompatibility was detected in the same way [2].
Table 1
LT4 absorption test result
Patient
Basal fT4a
Peak fT4
BMI (kg/m2)
Absorption (%)
1
0.636
0.639
27
6
2
0.290
0.440
27
40
3
0.400
2.000
47
166
4
0.200
1.300
26
97
5
0.530
1.980
30
90
aReference range of normal fT4 level is 0.89–1.76 ng/dL
Patient 1: [(0.639−0.636) × 4.42 × 27÷1000] × 100 = %0.035
Patient 2: [(0.440−0.290) × 4.42 × 27÷1000] × 100 = %1.79
Patient 3: [(2.000−0.400) × 4.42 × 47÷1000] × 100 = %33.2
Patient 4: [(1.300−0.200) × 4.42 × 26÷1000] × 100 = %12.64
Patient 5: [(1.980−0.530) × 4.42 × 30÷1000] × 100 = %19.27
Bold values in the table from orjinal study
As a result, the reliability of this formula, which is used to evaluate the absorption of levotroxin in patients with persistent elevation of TSH despite levothyroxine replacement therapy, is controversial and there are studies in which an increase of 50–100% in basal free T4 is accepted to evaluate malabsorption [3].

Compliance with ethical standards

Conflict of interest

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat IlginYildirim Simsir, UtkuErdem Soyaltin, AhmetGokhan Ozgen, Levothyroxine absorption test results in patients with TSH elevation resistant to treatment. Endocrine 64, 118–121 (2019)CrossRef IlginYildirim Simsir, UtkuErdem Soyaltin, AhmetGokhan Ozgen, Levothyroxine absorption test results in patients with TSH elevation resistant to treatment. Endocrine 64, 118–121 (2019)CrossRef
2.
Zurück zum Zitat GraceE.Ching Sun et al. The clinical utility of free thyroxine in oral levothyroxine absorption testing. Endocr. Pract. 20, 925–929 (2014)CrossRef GraceE.Ching Sun et al. The clinical utility of free thyroxine in oral levothyroxine absorption testing. Endocr. Pract. 20, 925–929 (2014)CrossRef
3.
Zurück zum Zitat KennethB. Ain et al. Pseudomalabsorption of levothyroxine. JAMA 266, 2118–2120 (1991)CrossRef KennethB. Ain et al. Pseudomalabsorption of levothyroxine. JAMA 266, 2118–2120 (1991)CrossRef
Metadaten
Titel
Letter to “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment”
verfasst von
Sadettin Öztürk
Ersin Akarsu
Publikationsdatum
20.07.2021
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2021
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02808-9

Weitere Artikel der Ausgabe 3/2021

Endocrine 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.